Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 29, 2016 16:30 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics, Inc. Appoints Hayden Jeffreys as Interim Chief Executive Officer

MIAMI, Nov. 29, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (OTC PINK:ERBA) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, effective as of January 1,...
September 30, 2016 16:00 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics to Commence Trading on OTC Markets’ Pink Open Market After Delisting by the NYSE MKT

MIAMI, Sept. 30, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (the “Company”), a fully integrated in vitro diagnostics company, previously disclosed that the Company expected the NYSE MKT LLC...
September 29, 2016 16:05 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics, Inc. Announces Inability to Meet Deadline to Regain Compliance With NYSE MKT Continued Listing Standards

MIAMI, Sept. 29, 2016 (GLOBE NEWSWIRE) -- As previously reported, ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, implemented during the third...
August 26, 2016 16:15 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards

MIAMI, Aug. 26, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, on August 23, 2016, the Company...
May 31, 2016 16:15 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics, Inc. Announces Extension of CEO’S Contract Term and Appointment of Hayden Jeffreys to Board of Directors

MIAMI, May 31, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that it has entered into an amendment...
May 20, 2016 16:15 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan

MIAMI, May 20, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, on May 19, 2016, the Company...
April 21, 2016 16:45 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards

MIAMI, April 21, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, on April 15, 2016, the Company...
January 27, 2016 08:00 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics’ Compliance Plan Accepted by NYSE MKT

MIAMI, Jan. 27, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that the Company received a letter...
December 29, 2015 08:05 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics, Inc. Announces the Consummation of the Capital Infusion of $3.5 Million Into the Company

MIAMI LAKES, Fla., Dec. 29, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, has consummated the capital infusion of...
December 17, 2015 08:00 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics Inc. Annual General Meeting CEO’s Speech on the Company’s Progress in 2015

MIAMI LAKES, Fla., Dec. 17, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) At ERBA Diagnostics, Inc.’s annual meeting of stockholders held on December 15, 2015, Mohan Gopalkrishnan,...